IRADIMED CORPORATION Reports Second Quarter 2026 Financial Results
IRADIMED CORPORATION reported Q2 2026 revenue of $20.5 million, a slight increase from Q2 2025, and earnings per share of $0.41 GAAP and $0.46 non-GAAP. The company launched its new 3870 MR IV pump with positive initial market acceptance and expects revenue and earnings growth in the back half of 2026, reaffirming full-year guidance. A quarterly ca…